Skip to search formSkip to main contentSkip to account menu

N-(4-methoxyphenyl)retinamide

Known as: N-all-trans-(4-Methoxyphenyl)retinamide, 4MPR, 4-MPR 
A phenylretinamide and synthetic retinoid analogue. N-(4-methoxyphenyl)retinamide (4-MPR) may activate retinoic acid receptors, thereby altering the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
BACKGROUND AND PURPOSE High plasma levels of fenretinide [N‐(4‐hydroxyphenyl)retinamide (4‐HPR)] were associated with improved… 
Highly Cited
2011
Highly Cited
2011
The dihydroceramide desaturase (DES) enzyme is responsible for inserting the 4,5-trans-double bond to the sphingolipid backbone… 
Highly Cited
2007
Highly Cited
2007
Purpose: Fenretinide [N-(4-hydroxyphenyl)retinamide (4-HPR)] is a cytotoxic retinoid that suffers from a wide interpatient… 
Highly Cited
1997
Highly Cited
1997
BACKGROUND The inhibitory effects of N-(4-hydroxyphenyl)retinamide (4HPR) on tumorigenesis and tumor growth may result from its… 
Highly Cited
1996
Highly Cited
1996
The activities of N-(4-hydroxyphenyl)retinamide [(4-HPR), Fenretinide] and all-trans-retinoic acid (RA) were determined for (a… 
Highly Cited
1995
Highly Cited
1995
Retinoid response pathways involve retinoic acid receptors (RARs) and retinoid X receptors. N-(4-hydroxyphenyl) retinamide (4-HPR… 
1995
1995
The cellular transport, metabolism and biological activity of retinoids are mediated by their specific binding proteins and… 
Highly Cited
1993
Highly Cited
1993
PURPOSE Monitoring of fenretinide (4HPR) levels, kinetics, and effects on retinal was performed in patients who participated in a… 
Highly Cited
1991
Highly Cited
1989
Highly Cited
1989
A study was conducted to determine whether N-(4-hydroxyphenyl)retinamide (4-HPR) affects the development of new mammary tumors…